Olaplex Q1 2025 Earnings Report
Key Takeaways
Olaplex reported a solid start to the year with first quarter net sales of $97.0 million, slightly ahead of expectations despite a 1.9% decrease year-over-year. Net income significantly decreased to $0.5 million compared to $7.7 million in the prior year, resulting in diluted EPS of $0.00. The company reiterated its full-year fiscal 2025 guidance.
Net sales for the first quarter of 2025 decreased 1.9% to $97.0 million.
Net income for the first quarter was $0.5 million, a significant decrease from $7.7 million in the prior year.
Diluted EPS was $0.00 for the first quarter, down from $0.01 in the same period last year.
The company reiterated its fiscal year 2025 guidance for net sales, adjusted gross profit margin, and adjusted EBITDA margin.
Olaplex
Olaplex
Olaplex Revenue by Segment
Forward Guidance
Olaplex reiterated its full-year fiscal 2025 guidance for net sales ($410 million - $431 million), adjusted gross profit margin (70.5% - 71.5%), and adjusted EBITDA margin (20% - 22%), incorporating planned strategic investments and the current consumer spending environment.
Positive Outlook
- Reiterated full-year guidance for key financial metrics.
- Includes planned investments in research and development.
- Includes planned investments in marketing initiatives.
- Includes planned investments in talent.
- Focus on driving demand and strengthening execution capabilities.
Challenges Ahead
- Guidance provided as a range, indicating potential variability.
- Incorporates the current consumer spending environment.
- Adjusted EBITDA Margin guidance (20-22%) is lower than FY2024 actual (30.7%).
- Assumes no material impact from tariffs.
- Second quarter expected to reflect a full quarter of incremental marketing investment.